The Gabelli Healthcare & Wellness Trust (NYSE:GRX - Get Free Report) major shareholder Saba Capital Management, L.P. bought 8,916 shares of the firm's stock in a transaction dated Thursday, November 5th. The stock was purchased at an average cost of $10.44 per share, for a total transaction of $93,083.04. Following the transaction, the insider directly owned 2,195,738 shares of the company's stock, valued at $22,923,504.72. The trade was a 0.41% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Saba Capital Management, L.P. also recently made the following trade(s):
- On Wednesday, November 4th, Saba Capital Management, L.P. purchased 700 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were purchased at an average cost of $10.43 per share, with a total value of $7,301.00.
- On Tuesday, November 3rd, Saba Capital Management, L.P. purchased 100 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was purchased at an average price of $10.18 per share, with a total value of $1,018.00.
- On Monday, November 2nd, Saba Capital Management, L.P. purchased 1,201 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was purchased at an average price of $10.15 per share, with a total value of $12,190.15.
- On Friday, October 30th, Saba Capital Management, L.P. acquired 10,196 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was purchased at an average cost of $10.13 per share, for a total transaction of $103,285.48.
- On Thursday, October 29th, Saba Capital Management, L.P. acquired 500 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were purchased at an average price of $10.09 per share, for a total transaction of $5,045.00.
- On Tuesday, October 27th, Saba Capital Management, L.P. acquired 300 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were purchased at an average price of $9.99 per share, for a total transaction of $2,997.00.
- On Monday, October 26th, Saba Capital Management, L.P. bought 1,284 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were purchased at an average cost of $10.00 per share, with a total value of $12,840.00.
- On Thursday, October 15th, Saba Capital Management, L.P. bought 200 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was acquired at an average cost of $9.88 per share, with a total value of $1,976.00.
- On Thursday, October 8th, Saba Capital Management, L.P. bought 400 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was acquired at an average cost of $9.40 per share, with a total value of $3,760.00.
- On Wednesday, October 7th, Saba Capital Management, L.P. purchased 2,955 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was acquired at an average price of $9.43 per share, for a total transaction of $27,865.65.
The Gabelli Healthcare & Wellness Trust Price Performance
NYSE:GRX traded up $0.03 during mid-day trading on Friday, reaching $10.42. 20,607 shares of the company's stock were exchanged, compared to its average volume of 25,760. The Gabelli Healthcare & Wellness Trust has a one year low of $8.80 and a one year high of $10.64. The business's fifty day simple moving average is $9.86 and its two-hundred day simple moving average is $9.55.
The Gabelli Healthcare & Wellness Trust Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 16th were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date was Wednesday, September 16th.
Institutional Investors Weigh In On The Gabelli Healthcare & Wellness Trust
A number of hedge funds and other institutional investors have recently made changes to their positions in GRX. Blue Bell Private Wealth Management LLC increased its stake in shares of The Gabelli Healthcare & Wellness Trust by 10.4% in the third quarter. Blue Bell Private Wealth Management LLC now owns 361,780 shares of the investment management company's stock valued at $3,441,000 after buying an additional 34,122 shares during the period. Gamco Investors INC. ET AL lifted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 1.1% during the first quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company's stock worth $3,132,000 after purchasing an additional 3,800 shares during the period. Aviance Capital Partners LLC grew its stake in shares of The Gabelli Healthcare & Wellness Trust by 0.8% in the third quarter. Aviance Capital Partners LLC now owns 172,847 shares of the investment management company's stock worth $1,644,000 after purchasing an additional 1,405 shares during the last quarter. Uhlmann Price Securities LLC grew its stake in shares of The Gabelli Healthcare & Wellness Trust by 4.6% in the third quarter. Uhlmann Price Securities LLC now owns 81,269 shares of the investment management company's stock worth $773,000 after purchasing an additional 3,569 shares during the last quarter. Finally, Private Advisor Group LLC grew its stake in shares of The Gabelli Healthcare & Wellness Trust by 25.2% in the first quarter. Private Advisor Group LLC now owns 19,888 shares of the investment management company's stock worth $180,000 after purchasing an additional 4,000 shares during the last quarter.
The Gabelli Healthcare & Wellness Trust Company Profile
(
Get Free Report)
The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company focused on long-term growth of capital. Rather than operating healthcare facilities or selling healthcare products directly, the trust invests in the securities of companies involved in healthcare and wellness.
Its portfolio may include companies across areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, diagnostics, consumer health, fitness and other wellness-related industries.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
